课题基金 / 基金详情

EFFECT OF 12 WKS OF COLESEVELAM ON INSULIN SENSITIVITY & ORAL GLUCOSE ABSORPTION

EFFECT OF 12 WKS OF COLESEVELAM ON INSULIN SENSITIVITY & ORAL GLUCOSE ABSORPTION
12 周考来维仑对胰岛素敏感性的影响
批准号：
7606565
负责人：
Robert Roy Henry
金额：
$4.19万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
项目状态：
已结题
起止时间：
2006-12-01 至 2007-11-30
来源：
https://reporter.nih.gov/project-details/7606565
关键词：
Computer Retrieval of Information on Scientific Projects DatabaseDailyFundingGlucoseGrantHepaticInstitutionNon-Insulin-Dependent Diabetes MellitusOralPeripheralResearchResearch PersonnelResourcesSourceUnited States National Institutes of HealthWeekabsorptioncolesevelamglycemic controlinsulin sensitivity

项目摘要

项目成果

Robert Roy Henry的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. In subjects with Type 2 diabetes with inadequate glycemic control on oral therapy study 1. Evaluate the effect of colesevelam 3.8 g administered daily for 12 weeks, on hepatic insulin sensitivity. 2. Evaluate the effect of colesevelam 3.8g administered daily for 12 weeks on peripheral insulin sensitivity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epicatechin and derivatives to preserve muscle structure function in diabetes
Epicatechin and derivatives to preserve muscle structure function in diabetes
Epicatechin and derivatives to preserve muscle structure function in diabetes
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin
海外基金